We spoke to Enovis CEO Matt Trerotola about foundational implant technologies, ASC penetration, tech adoption and successful M&A deals.
The Numbers
Enovis reported 4Q22 orthopedic sales of $162.5 million, +10.4% compared to 4Q21. Including contributions from acquisitions, the company generated $599.4…
Our chart of the month shows the projected top 10 largest players in spine after recent M&A deals in the market segment.
Orthoflash®
Further, the USPTO intends to grant a patent for the conversion of the design from a hemi-arthroplasty to a total arthroplasty.
March 21, 2023
,
The system enables flexible treatment of fractures of the distal humerus and olecranon important to the elbow function and stability.
March 21, 2023
,
A new clinical study demonstrates Medacta’s MySpine accuracy in screw replacement during spine revision surgery.
March 21, 2023
,
The expanded clearance extends the clinical benefits of Precice to a wider range of patients, namely pediatrics.
March 20, 2023
,
The next iteration of HOLO Portal delivers advancements based on early clinical experience and insights from leading spine surgeons in the U.S.
March 20, 2023
,
Competitive Landscape
ORTHOWORLD Experts talk you through market forecasts, company sales and key trends.
Industry Voices
